Loading company…
Softhale develops inhaler devices for delivering respiratory medicines to the lungs.
Softhale develops a propellant-free mechanical device for delivering inhalable medicines to the lungs. Its products are intended for respiratory diseases and infections including asthma, tuberculosis, pneumonia, and COPD. Founded in 2016, the company is based in Limburg, Belgium, and is an invoX company. New Rhein Healthcare Investors acquired it in 2018.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in